Therapeutic Potential of Targeting Regulatory Mechanisms of Hepatic Stellate Cell Activation in Liver Fibrosis.
DRUG DISCOVERY TODAY(2022)
摘要
Hepatic fibrosis is a manifestation of different etiologies of liver disease with the involvement of multiple mediators in complex network interactions. Activated hepatic stellate cells (aHSCs) are the central driver of hepatic fibrosis, given their potential to induce connective tissue formation and extracellular matrix (ECM) protein accumulation. Therefore, identifying the cellular and molecular pathways involved in the activation of HSCs is crucial in gaining mechanistic and therapeutic perspectives to more effectively target the disease. In addition to a comprehensive summary of our current understanding of the role of HSCs in liver fibrosis, we also discuss here the proposed therapeutic strategies based on targeting HSCs.
更多查看译文
关键词
Liver diseases,Extracellular signaling,Cell phenotype,Fibrogenic myofibroblasts,Autophagy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要